Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Gert Bernstein

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Handbook of Clinical Neurology|July 16, 2021
The implications of hypothalamic abnormalities for schizophreniaHans-Gert Bernstein, Gerburg Keilhoff, Johann Steiner
Clinical Nutrition (Edinburgh, Scotland)|January 17, 2018
Some notes on citrulline in the CNSHans-Gert Bernstein, Gerburg Keilhoff, Johann Steiner
Expert Review of Neurotherapeutics|July 11, 2009
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapyHans-Gert Bernstein, Johann Steiner, Bernhard Bogerts
Schizophrenia Research|July 12, 2005
The many faces of nitric oxide in schizophrenia. A reviewHans-Gert Bernstein, Bernhard Bogerts, Gerburg Keilhoff
Arteriosclerosis, Thrombosis, and Vascular Biology|November 21, 2008
Cathepsin K and metabolic abnormalities in schizophreniaHans-Gert Bernstein, Bernhard Bogerts, Uwe Lendeckel
Frontiers in Cellular Neuroscience|March 5, 2016
Commentary: Maternal immune activation evoked by polyinosinic: polycytidylic acid does not evoke microglial cell activation in the embryoHans-Gert Bernstein, Yael Piontkewitz, Gerburg Keilhoff
Medical Hypotheses|January 20, 2004
Electro-convulsive therapy, nitric oxide and HPA axis: a closer look at human hypothalamusHans Gert Bernstein, Arndt Heinemann, Bernhard Bogerts
Journal of Psychiatric Research|August 30, 2011
Do elevated glucocorticoids contribute to reduced cerebral expression of insulin-degrading enzyme in schizophrenia?Hans-Gert Bernstein, Uwe Lendeckel, Johann Steiner, et al.
Molecular Medicine Reports|April 21, 2015
Effects of nitric oxide synthase deficiency on a disintegrin and metalloproteinase domain-containing protein 12 expression in mouse brain samplesUwe Lendeckel, Carmen Wolke, Hans-Gert Bernstein, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 24, 2020
SLC Solute Carrier Transporters and Neurodegenerative Disorders: Drawing Attention to Cationic Amino Acid Transporters 1 and 2Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Handbook of Clinical Neurology|July 16, 2021
The implications of hypothalamic abnormalities for schizophreniaHans-Gert Bernstein, Gerburg Keilhoff, Johann Steiner
Clinical Nutrition (Edinburgh, Scotland)|January 17, 2018
Some notes on citrulline in the CNSHans-Gert Bernstein, Gerburg Keilhoff, Johann Steiner
Expert Review of Neurotherapeutics|July 11, 2009
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapyHans-Gert Bernstein, Johann Steiner, Bernhard Bogerts
Schizophrenia Research|July 12, 2005
The many faces of nitric oxide in schizophrenia. A reviewHans-Gert Bernstein, Bernhard Bogerts, Gerburg Keilhoff
Arteriosclerosis, Thrombosis, and Vascular Biology|November 21, 2008
Cathepsin K and metabolic abnormalities in schizophreniaHans-Gert Bernstein, Bernhard Bogerts, Uwe Lendeckel
Frontiers in Cellular Neuroscience|March 5, 2016
Commentary: Maternal immune activation evoked by polyinosinic: polycytidylic acid does not evoke microglial cell activation in the embryoHans-Gert Bernstein, Yael Piontkewitz, Gerburg Keilhoff
Medical Hypotheses|January 20, 2004
Electro-convulsive therapy, nitric oxide and HPA axis: a closer look at human hypothalamusHans Gert Bernstein, Arndt Heinemann, Bernhard Bogerts
Journal of Psychiatric Research|August 30, 2011
Do elevated glucocorticoids contribute to reduced cerebral expression of insulin-degrading enzyme in schizophrenia?Hans-Gert Bernstein, Uwe Lendeckel, Johann Steiner, et al.
Molecular Medicine Reports|April 21, 2015
Effects of nitric oxide synthase deficiency on a disintegrin and metalloproteinase domain-containing protein 12 expression in mouse brain samplesUwe Lendeckel, Carmen Wolke, Hans-Gert Bernstein, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 24, 2020
SLC Solute Carrier Transporters and Neurodegenerative Disorders: Drawing Attention to Cationic Amino Acid Transporters 1 and 2Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, et al.
Pageof 19